Haleos Labs Limited

HALEOSLABS NSE Healthcare Pharmaceuticals
₹1,455.00
+0.30%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Haleos Labs Limited belong to?
Haleos Labs Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.
What is the current share price of HALEOSLABS?
As of the latest available quote, HALEOSLABS traded at ₹1,455.00. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of HALEOSLABS?
Haleos Labs Limited has a price-to-earnings (P/E) ratio of about 27.87. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of HALEOSLABS?
The market capitalisation of Haleos Labs Limited is approximately ₹442 Cr.
Is Haleos Labs Limited profitable?
For its latest reported financial year, Haleos Labs Limited recorded a net profit margin of about 5.39%.
Does HALEOSLABS pay a dividend?
Haleos Labs Limited does not currently show a dividend yield in our data.
What is the return on equity (ROE) of HALEOSLABS?
Haleos Labs Limited has a return on equity (ROE) of about 8.44%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of HALEOSLABS?
Over the past 52 weeks, HALEOSLABS has traded between a low of ₹1,091.10 and a high of ₹1,774.00.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.